Related Experiment Video
Updated: Apr 22, 2026
Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
Transplantation in rare lymphoproliferative and histiocytic disorders
Alexis Cruz-Chacon1, John Mathews, Ernesto Ayala
1Department of Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL 33612, USA. Ernesto.Ayala@Moffitt.org.
Background:
Some uncommon lymphoproliferative and histiocytic disorders may present with an aggressive course and require hematopoietic stem cell transplantation (HSCT) as part of the therapeutic approach.
Methods:
Published research on the use of HSCT for the treatment of these disorders was reviewed and summarized.
Results:
Allogeneic HSCT may be indicated in patients with blastic plasmacytoid dendritic cell neoplasia, familial or secondary recurrent hemophagocytic lymphohistiocytosis, and resistant Langerhans cell histiocytosis. Autologous HSCT may be considered in patients with Castleman disease resistant to treatment. No role has been established for the use of HSCT for dendritic cell sarcoma.
Conclusions:
HSCT has an evolving role in the treatment of select aggressive lymphoproliferative and histiocytic disorders.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
01:24Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:40Cell-mediated Immune Responses
01:16Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...